Chatterton & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Buy
943
+12
+1% +$2.8K 0.14% 92
2026
Q1
$225K Buy
+931
New +$217K 0.16% 90

Other funds holding JNJ

Chatterton & Associates's JNJ Position: Q2 2026 in Review

Chatterton & Associates increased its Johnson & Johnson (JNJ) stake by 1.3% in Q2 2026, buying an estimated $2.8K and bringing the position to 943 shares worth $244K. The position accounts for 0.14% of the portfolio, ranked #92.

Chatterton & Associates first reported a position in JNJ in Q1 2026 and has held it in 2 quarters since. 2,987 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Chatterton & Associates held 943 shares of Johnson & Johnson worth $244K as of Q2 2026.
  • Chatterton & Associates bought 12 Johnson & Johnson shares in Q2 2026, an estimated $2.8K.
  • Johnson & Johnson made up 0.14% of Chatterton & Associates's portfolio in Q2 2026, its #92 holding.
  • Chatterton & Associates first reported a position in Johnson & Johnson in Q1 2026 and has held it in 2 quarters since.
  • 2,987 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Chatterton & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.